AIRLINK 217.98 Decreased By ▼ -4.91 (-2.2%)
BOP 10.93 Increased By ▲ 0.11 (1.02%)
CNERGY 7.55 Decreased By ▼ -0.01 (-0.13%)
FCCL 34.83 Decreased By ▼ -2.24 (-6.04%)
FFL 19.32 Increased By ▲ 0.08 (0.42%)
FLYNG 25.15 Decreased By ▼ -1.89 (-6.99%)
HUBC 131.09 Decreased By ▼ -1.55 (-1.17%)
HUMNL 14.56 Decreased By ▼ -0.17 (-1.15%)
KEL 5.18 Decreased By ▼ -0.22 (-4.07%)
KOSM 7.36 Decreased By ▼ -0.12 (-1.6%)
MLCF 45.63 Decreased By ▼ -2.55 (-5.29%)
OGDC 222.08 Decreased By ▼ -1.18 (-0.53%)
PACE 8.16 Decreased By ▼ -0.02 (-0.24%)
PAEL 44.19 Increased By ▲ 0.69 (1.59%)
PIAHCLA 17.69 Decreased By ▼ -0.37 (-2.05%)
PIBTL 8.97 Decreased By ▼ -0.10 (-1.1%)
POWERPS 12.51 Decreased By ▼ -0.50 (-3.84%)
PPL 193.01 Decreased By ▼ -5.23 (-2.64%)
PRL 43.17 Increased By ▲ 0.93 (2.2%)
PTC 26.63 Decreased By ▼ -0.76 (-2.77%)
SEARL 107.08 Decreased By ▼ -3.00 (-2.73%)
SILK 1.04 Decreased By ▼ -0.02 (-1.89%)
SSGC 45.00 Decreased By ▼ -2.30 (-4.86%)
SYM 21.19 Increased By ▲ 0.42 (2.02%)
TELE 10.15 Decreased By ▼ -0.37 (-3.52%)
TPLP 14.51 Decreased By ▼ -0.44 (-2.94%)
TRG 67.28 Decreased By ▼ -1.57 (-2.28%)
WAVESAPP 11.29 Decreased By ▼ -0.63 (-5.29%)
WTL 1.70 Decreased By ▼ -0.09 (-5.03%)
YOUW 4.25 Decreased By ▼ -0.10 (-2.3%)
BR100 12,397 Increased By 33.3 (0.27%)
BR30 37,347 Decreased By -871.2 (-2.28%)
KSE100 117,587 Increased By 467.3 (0.4%)
KSE30 37,065 Increased By 128 (0.35%)
Editorials

Scientists close to HIV cure in humans after treating mice through gene-editing

In light of a recent breakthrough where scientists cured HIV via gene-editing in living animals, scientists now bel
Published July 4, 2019 Updated July 8, 2019

In light of a recent breakthrough where scientists cured HIV via gene-editing in living animals, scientists now believe that they are closer to finding a cure for HIV for humans too.

For the first time ever, researchers have cured HIV, the virus that leads to AIDS, from the genes of living mice through CRISPR gene-editing. This discovery marks as a great achievement along the path to freeing humans from the lethal disease.

The team started by engineering mice to create human T cells susceptible to HIV infection. After infecting the mice, the researchers used a therapeutic strategy called long-acting slow-effective release antiretroviral therapy (LASER ART) in order to suppress HIV replication within mice, reported Futurism.

Gene-editing tech could make people immune to flu, HIV in future

In the end, the team then used CRISPR gene-editing technology for removing HIV DNA from the infected cells. After later analyzing the animals, it was discovered that about one-third of the animals showed no signs of HIV.

Next, the team plans on combining LASER ART and CRISPR therapy in non-human primates. If those trials go successful, the human trials will initiate within the year, as per researcher Kamel Khalili. However, though optimistic, they do realize the hurdles they would have to cross.

“Things that work in mice, may not work in men,” researcher Howard Gendelman told CNBC. “The limitations of any mouse work have to do with the species, how the drug is administered, the distribution, which is a lot easier than a man or a woman.”

Copyright Business Recorder, 2019

Comments

Comments are closed.